CLASS II Drug recall · Reported 29 Jun 2016 · FDA Enforcement Report

tabcin Active M.R recalled by Profarma Distributors

Profarma Distributors is recalling tabcin Active M.R, distributed nationwide in the US. The recall was initiated on 11 May 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 224TS; Exp. 02/17
Quantity recalled42 boxes (504 capsules)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1039-2016
FDA event ID
74135
Recalling firm
Profarma Distributors, Columbus, OH
Classification
Class II
Status
Terminated
Recall initiated
11 May 2016
FDA classified
17 Jun 2016
Reported
29 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

11 May 2016Recall initiated by company
17 Jun 2016Classified by FDA+37 days
29 Jun 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations

Product as listed by the FDA

tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is tabcin Active M.R recalled?

Yes. Profarma Distributors recalled tabcin Active M.R on 11 May 2016. The recall is Class II and its status is Terminated. Recall number D-1039-2016.

Why was it recalled?

CGMP Deviations

Which lots are affected?

Lot # 224TS; Exp. 02/17

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Profarma Distributors

All 5